Do subjective memory complaints herald the onset of mild cognitive impairment in Parkinson disease?

Journal of Geriatric Psychiatry and Neurology

Volumn 27, Issue 4, 2014, Pages 276-281

  Erro, Roberto ^a   Santangelo, Gabriella ^b,c   Barone, Paolo ^d   Picillo, Marina ^e   Amboni, Marianna ^c   Longo, Katia ^c   Giordano, Flavio ^d   Moccia, Marcello ^e   Allocca, Roberto ^e   Pellecchia, Maria Teresa ^d   Vitale, Carmine ^c,f  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b SECOND UNIVERSITY OF NAPLES   (Italy)

^c Neurology   (Italy)

^d UNIVERSITY OF SALERNO   (Italy)

^e UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^f UNIVERSITY OF NAPLES PARTHENOPE   (Italy)

Author keywords

cognitive impairment; cognitive testing; Parkinson disease

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; MALE; MEMORY DISORDER; MILD COGNITIVE IMPAIRMENT; NEUROPSYCHOLOGICAL TEST; ONSET AGE; PARKINSON DISEASE; RISK ASSESSMENT; SCREENING; COMPLICATION; DISEASE COURSE; EDUCATIONAL STATUS; MEMORY; MEMORY DISORDERS; MIDDLE AGED; PREDICTIVE VALUE; PROSPECTIVE STUDY; PSYCHOLOGICAL RATING SCALE; PSYCHOLOGY; QUESTIONNAIRE; STATISTICAL MODEL; STATISTICS AND NUMERICAL DATA;

AGED; DISEASE PROGRESSION; EDUCATIONAL STATUS; FEMALE; FOLLOW-UP STUDIES; HUMANS; LOGISTIC MODELS; MALE; MEMORY; MEMORY DISORDERS; MIDDLE AGED; MILD COGNITIVE IMPAIRMENT; NEUROPSYCHOLOGICAL TESTS; PARKINSON DISEASE; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; PSYCHIATRIC STATUS RATING SCALES; QUESTIONNAIRES;

EID: 84910029242     PISSN: 08919887     EISSN: 15525708     Source Type: Journal    
DOI: 10.1177/0891988714532015     Document Type: Article

References (49)

1. Postuma RB, Aarsland D, Barone P, et al. Identifying prodromal Parkinson's disease: pre-motor disorders in Parkinson's disease. Mov Disord. 2012 ; 27 (5). 617-626
2. Erro R, Santangelo G, Picillo M, et al. Link between non-motor symptoms and cognitive dysfunctions in de novo, drug-naive PD patients. J Neurol. 2012 ; 259 (9). 1808-1813
3. Hely MA, Reid WG, Adena MA, Halliday GM, Morris JG. The Sydney multicenter study of Parkinson's disease: the inevitability of dementia at 20 years. Mov Disord. 2008 ; 23 (6). 837-844
4. Aarsland D, Larsen JP, Tandberg E, Laake K. Predictors of nursing home placement in Parkinson's disease: a population-based, prospective study. J Am Geriatr Soc. 2000 ; 48 (8). 938-942
5. Findley L, Aujla M, Bain PG, et al. Direct economic impact of Parkinson's disease: a research survey in the United Kingdom. Mov Disord. 2003 ; 18 (10). 1139-1145
6. Litvan I, Goldman JG, Troster AI, et al. Diagnostic criteria for mild cognitive impairment in Parkinson's disease: movement disorder society task force guidelines. Mov Disord. 2012 ; 27 (3). 349-356
7. Jessen F, Wiese B, Bachmann C, et al. Prediction of dementia by subjective memory impairment: effects of severity and temporal association with cognitive impairment. Arch Gen Psychiatry. 2010 ; 67 (4). 414-422
8. Litvan I, Aarsland D, Adler CH, et al. MDS task force on mild cognitive impairment in Parkinson's disease: critical review of PD-MCI. Mov Disord. 2011 ; 26 (10). 1814-1824
9. Jessen F, Wiese B, Bachmann C, et al. Prediction of dementia by subjective memory impairment: effects of severity and temporal association with cognitive impairment. Arch Gen Psychiatry. 2010 ; 67 (4). 414-422
10. Stewart R, Godin O, Crivello F, et al. Longitudinal neuroimaging correlates of subjective memory impairment: 4-year prospective community study. Br J Psychiatry. 2011 ; 198 (3). 199-205
11. Mosconi L, De Santi S, Brys M, et al. Hypometabolism and altered cerebrospinal fluid markers in normal apolipoprotein E E4 carrier with subjective memory complains. Biol Psychiatry. 2008 ; 63 (6). 609-618
12. Perrotin A, Mormino EC, Madison CM, Hayenga AO, Jagust WJ. Subjective cognition and amyloid deposition imaging: a Pittsburgh compound B positron emission tomography study in normal elderly individuals. Arch Neurol. 2012 ; 69 (2). 223-229
13. Visser PJ1, Verhey F, Knol DL. Prevalence and prognostic value of CSF markers of Alzheimer's disease pathology in patients with subjective cognitive impairment or mild cognitive impairment in the DESCRIPA study: a prospective cohort study. Lancet Neurol. 2009 ; 8 (7). 619-627
14. Koerts J, van Beilen M, Leenders KL, Brouwer WH, Tucha L, Tucha O. Complaints about impairments in executive functions in Parkinson's disease: the association with neuropsychological assessment. Parkinsonism Relat Disord. 2012 ; 18 (2). 194-197
15. Koerts J, Tucha L, Leenders KL, van Beilen M, Brouwer WH, Tucha O. Subjective and objective assessment of executive functions in Parkinson's disease. J Neurol Sci. 2011 ; 310 (1-2). 172-175
16. Dujardin K, Duhamel A, Delliaux M, Thomas-Antérion C, Destée A, Defebvre L. Cognitive complaints in Parkinson's disease: its relationship with objective cognitive decline. J Neurol. 2010 ; 257 (1). 79-84
17. Santangelo G, Vitale C, Trojano L, et al. Relationship between depression and cognitive dysfunctions in Parkinson's disease without dementia. J Neurol. 2009 ; 256 (4). 632-638
18. Santangelo G, Vitale C, Trojano L, et al. Subthreshold depression and subjective cognitive complaints in Parkinson's disease. Eur J Neurol. 2014 ; 21 (3). 541-544
19. Kulisevsky J, Garcia-Sanchez C, Berthier ML, et al. Chronic effects of dopaminergic replacement on cognitive function in Parkinson's disease: a two-year follow-up study of previously untreated patients. Mov Disord. 2000 ; 15 (4). 613-626
20. Fera F, Nicoletti G, Cerasa A, et al. Dopaminergic modulation of cognitive interference after pharmacological washout in Parkinson's disease. Brain Res Bull. 2007 ; 74 (1-3). 75-83
21. Erro R, Picillo M, Vitale C, et al. Non-motor symptoms in early Parkinson's disease: a 2-year follow-up study on previously untreated patients. J Neurol Neurosurg Psychiatry. 2013 ; 84 (1). 14-17
22. Erro R, Vitale C, Amboni M, et al. The heterogeneity of early Parkinson's disease: a cluster analysis on newly diagnosed untreated patients. PLoS One. 2013 ; 8 (8). e70244
23. Erro R, Santangelo G, Picillo M, et al. Side of onset does not influence cognition in newly diagnosed untreated Parkinson's disease patients. Parkinsonism Relat Disord. 2013 ; 19 (2). 256-259
24. Erro R, Pappatà S, Amboni M, et al. Anxiety is associated with striatal dopamine transporter availability in newly diagnosed untreated Parkinson's disease patients. Parkinsonism Relat Disord. 2012 ; 18 (9). 1034-1038
25. Pappatà S, Santangelo G, Aarsland D, et al. Mild cognitive impairment in drug-naive patients with PD is associated with cerebral hypometabolism. Neurology. 2011 ; 77 (14). 1357-1362
26. Hoehn MM, Yahr MD. Parkinsonism: onset, progression and mortality. Neurology. 1967 ; 17 (5). 427-442
27. Fahn S, Elton RL, program members UPDRS Recent Developments in Parkinson's Disease. Fahn S Mardsen CD Goldstein M Calne DB, ed. Florham Park, NJ: Macmillan Healthcare Information ; 1987: 153-163.
28. Caffarra P, Vezzadini G, Dieci F, Zonato F, Venneri A. Rey-Osterrieth complex figure: normative values in an Italian population sample. Neurol Sci. 2002 ; 22 (6). 443-447
29. Spinnler H, Tognoni G. Standardizzazione e taratura italiana di una batteria di test neuropsicologici. Ital J Neurol Sci. 1987 ; 6 (suppl 8). 20-120
30. Benton AL, Varney NR, Hamsher KD. Visuospatial judgment: a clinical test. Arch Neurol. 1978 ; 35 (6). 364-367
31. Mondini S, Mapelli D, Vestri A, Bisiacchi P L'Esame Neuropsicologico Breve. Milano: Raffaello Cortina Editore ; 2003 :
32. Appollonio I, Leone M, Isella V, et al. The frontal assessment battery (FAB): normative values in an Italian population sample. Neurol Sci. 2005 ; 26 (2). 108-116
33. Carlesimo GA, Caltagirone C, Gainotti G. The mental deterioration battery: normative data, diagnostic reliability and qualitative analyses of cognitive impairment. The group for the standardization of the mental deterioration battery. Eur Neurol. 1996 ; 36 (6). 378-384
34. Giovagnoli AR, Del Pesce M, Mascheroni S, Simoncelli M, Laiacona M, Capitani E. Trail making test: normative values from 287 normal adult controls. Ital J Neurol Sci. 1996 ; 17 (4). 305-309
35. Barbarotto R, Laiacona M, Frosio R, Vecchio M, Farinato A, Capitani E. A normative study on visual reaction times and two Stroop colour word tests. Ital J Neurol Sci. 1998 ; 19 (3). 161-170
36. Tröster AI, Woods SP, Morgan EE. Assessing cognitive change in Parkinson's disease: development of practice effect-corrected reliable change indices. Arch Clin Neuropsychol. 2007 ; 22 (6). 711-718
37. Kieburtz K, McDermott M, Como P, et al. The effect of deprenyl and tocopherol on cognitive performance in early untreated Parkinson's disease. Parkinson study group. Neurology. 1994 ; 44 (9). 1756-1759
38. Azuma T, Cruz RF, Bayles KA, Tomoeda CK, Montgomery EB. A longitudinal study of neuropsychological change in individuals with Parkinson's disease. Int J Geriatr Psychiatry. 2003 ; 18 (11). 1043-1049
39. Aarsland D, Bronnick K, Williams-Gray C, et al. Mild cognitive impairment in Parkinson disease. A multicenter pooled analysis. Neurology. 2010 ; 75 (12). 1062-1069
40. Martinez-Martin P, Schapira AHV, Stocchi F, et al. Prevalence of nonmotor symptoms in Parkinson's Disease in an international setting; study using nonmotor symptoms questionnaire in 545 patients. Mov Disord. 2007 ; 22 (11). 1623-1629
41. Leentjens AF, Dujardin K, Marsh L, Richard IH, Starkstein SE, Martinez-Martin P. Anxiety rating scales in Parkinson's disease: a validation study of the Hamilton anxiety rating scale, the Beck anxiety inventory, and the hospital anxiety and depression scale. Mov Disord. 2011 ; 26 (3). 407-415
42. Ivory SJ, Knight RG, Longmore BE, Caradoc-Davies T. Verbal memory in non-demented patients with idiopathic Parkinson's disease. Neuropsychologia. 1999 ; 37 (7). 817-828
43. Foltynie T, Brayne CE, Robbins TW, Barker RA. The cognitive ability of an incident cohort of Parkinson's patients in the UK. The CamPaIGN study. Brain. 2004 ; 127 (pt 3). 550-560
44. Williams-Gray CH, Evans JR, Goris A, et al. The distinct cognitive syndromes of Parkinson's disease: 5 year follow-up of the CamPaIGN cohort. Brain. 2009 ; 132 (pt 11). 2958-2969
45. Johnson AM, Pollard CC, Vernon PA, Tomes JL, Jog MS. Memory perception and strategy use in Parkinson's disease. Parkinsonism Relat Disord. 2005 ; 11 (2). 111-115
46. Litvan I, Goldman JG, Troster AI, et al. Reply: mild cognitive impairment in De Novo Parkinson's disease according to movement disorder guidelines. Mov Disord. 2012 ; 27 (13). 1707
47. Marino SE, Meador KJ, Loring DW, et al. Subjective perception of cognition is related to mood and not performance. Epilepsy Behav. 2009 ; 14 (3). 459-464
48. Gerstorf D, Siedlecki KL, Tucker-Drob EM, Salthouse TA. Executive dysfunctions across adulthood: measurement properties and correlates of the DEX self-report questionnaire. Neuropsychol Dev Cogn B Aging Neuropsychol Cogn. 2008 ; 15 (4). 424-445
49. Sitek EJ, Sotan W, Wieczorek D, Robowski P, Sawek J. Self-awareness of memory function in Parkinson's disease in relation to mood and symptom severity. Aging Ment Health. 2011 ; 15 (2). 150-156